Phoenix Biotech Acquisition Corp.

General Information

We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries in the United States and Europe. In particular, we intend to prioritize companies in the life sciences sector where our management team has extensive experience.

(Note: Phoenix Biotech Acquisition Corp. priced its SPAC IPO on Oct. 5, 2021, in line with the term in its prospectus: 15.5 million units at $10 each to raise $155 million.)

Employees: 0
Founded: 2021
Contact Information
Address 2201 Broadway, Suite 705 Oakland, CA 94612
Phone Number (215) 731-9450
Web Address
View Prospectus: Phoenix Biotech Acquisition Corp.
Financial Information
Market Cap $204.31mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol PBAXU
Exchange NASDAQ
Shares (millions): 15.5
Price range $10.00 - $10.00
Est. $ Volume $155.0 mil
Manager / Joint Managers Cantor Fitzgerald
CO-Managers -
Expected To Trade: 10/6/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change